Annovis Bio Inc
(ANVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2 | 35 | N/A | N/A | N/A |
| Receivables | 735 | N/A | N/A | N/A | N/A |
| TOTAL | $748 | $51 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 370 | 0 | 0 | 0 | 0 |
| TOTAL | $370 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $1,117 | $51 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,234 | 68 | 0 | 0 | 0 |
| Accrued Expenses | 777 | 500 | N/A | N/A | N/A |
| TOTAL | $2,011 | $568 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7,577 | 7,077 | 0 | 0 | 0 |
| TOTAL | $7,683 | $7,077 | $N/A | $N/A | $N/A |
| Total Liabilities | $9,694 | $7,645 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Retained earnings | -8,777 | -7,786 | N/A | N/A | N/A |
| TOTAL | $-8,576 | $-7,594 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $1,117 | $51 | $0 | $0 | $0 |